Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature review by Jona F. Houthuys, Alexander P. Wilmer, Marijke Peetermans, Philippe Meersseman, Timothy Devos

Subjects: “…Ruxolitinib…”
Get full text

Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: a case report by Colomba Claudia, Rubino Raffaella, Siracusa Lucia, Lalicata Francesco, Trizzino Marcello, Titone Lucina, Tolomeo Manlio

Subjects: Get full text

Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis” by Meron Teklu, MD, Hye Jin Chung, MD, MMSc

Subjects: Get full text

Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib by Arthur E. Frankel, Renuka Reddy, Kayla R. DeSuza, Khaled Deeb, Aaron F. Carlin, Davey Smith, Yushuang Xie, Eknath Naik, Richard T. Silver, Hans C. Hasselbalch

Subjects: Get full text

Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project by Giacomo Coltro, Emanuela Sant'Antonio, Giuseppe A. Palumbo, Francesco Mannelli, Valerio De Stefano, Marco Ruggeri, Elena M. Elli, Roberta Zanotti, Oscar Borsani, Irene Bertozzi, Andrea Duminuco, Silvia Betti, Giuseppe Carli, Fabrizio Cavalca, Ilaria Tanasi, Elisa Rumi, Maria L. Randi, Bruno Garibaldi, Giuseppe G. Loscocco, Paola Guglielmelli, Alessandro M. Vannucchi

Subjects: Get full text

Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms by Eylem Eliaçık, Ayşe Işık, Salih Aksu, Ayşegül Üner, Yahya Büyükaşık, Nilgün Sayınalp, Hakan Göker, Osman İ. Özcebe, İbrahim C. Haznedaroğlu

Subjects: Get full text

Trends in overall mortality among US veterans with primary myelofibrosis by Tsewang Tashi, Jingbo Yu, Shivani Pandya, Christopher Dieyi, Robyn Scherber, Shreekant Parasuraman

Subjects: Get full text

Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report by Meltem Aylı, Muhit Özcan, Güldane Cengiz Seval

Subjects: Get full text

Tuberculosis in Patients with Primary Myelofibrosis During Ruxolitinib Therapy: Case Series and Literature Review by Peng Y, Meng L, Hu X, Han Z, Hong Z

Subjects: Get full text

Ruxolitinib cream for the treatment of cutaneous sarcoidosis by Jeffrey S. Smith, MD, PhD, Michael J. Woodbury, BS, Joseph F. Merola, MD, MMSc

Subjects: Get full text

Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib by Sakiyama E, Chinen Y, Tsukamoto T, Takimoto-Shimomura T, Kuwahara-Ota S, Matsumura-Kimoto Y, Shimura Y, Kobayashi T, Horiike S, Kuroda J

Subjects: “…ruxolitinib…”
Get full text

Efficacy of topical ruxolitinib for cutaneous dermatomyositis by Aviya Lanis, MD, Hanna Kim, MD, MS, Shajia Lu, BS, Wanxia Li Tsai, MS, Amy Kaneshiro, BA, Alison Ehrlich, MD, MHS, George Martin, MD, Adam Schiffenbauer, MD, Susan Shenoi, MBBS, MS, RhMSUS

Subjects: Get full text

Psychometric Evaluation of the Facial and Total Vitiligo Area Scoring Index Instruments in the TRuE-V Phase 3 Studies by Kristen Bibeau, Kathleen Butler, Mingyue Wang, Konstantina Skaltsa, Iltefat H. Hamzavi

Subjects: Get full text

Report of novel treatment of segmental vitiligo using combined microneedling and topical ruxolitinib by Rama Abdin, Michael Kaiser, Naiem T. Issa

Subjects: Get full text

The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis by Martina Barone, Lucia Catani, Francesca Ricci, Marco Romano, Dorian Forte, Giuseppe Auteri, Daniela Bartoletti, Emanuela Ottaviani, Pier Luigi Tazzari, Nicola Vianelli, Michele Cavo, Francesca Palandri

Subjects: Get full text

Ruxolitinib Has a Protective Effect on Ovarian and Endometrial Tissues in Diabetic Rats via STAT3 Pathway by Savaş Özdemir, Fatih Şahin, Oytun Erbaş

Subjects: Get full text

Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53 by Qian Wang, Hai-ping Dai, Dan-dan Liu, Jun-dan Xie, Hong Yao, Zi-xuan Ding, Ting-ting Tao, Su-ning Chen, Ri Zhang

Subjects: Get full text

Ruxolitinib: a targeted treatment option for patients with polycythemia vera by Vaddi K, Verstovsek S, Kiladjian JJ

Subjects: Get full text

A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinib by Katya Prakash, Douglas Richman

Subjects: “…Ruxolitinib…”
Get full text

Ruxolitinib Alleviates Uveitis Caused by <i>Salmonella typhimurium</i> Endotoxin by Lin Du, Yolanda Wong Ying Yip, Him Kwan Ng, Bo Man Ho, Jing-Na He, Sun On Chan, Chi Pui Pang, Wai Kit Chu

Subjects: “…ruxolitinib…”
Get full text